|
RegenoCELL
Therapeutics
RegenoCELL
Therapeutics, Inc. (OTC BB: RCLL) will be among the first companies to
bring stem cell therapy treatments to the market. Our treatments for
Congestive Heart Failure and Peripheral Artery Disease provide hope for
patients who have until now been given limited options or none. These
revolutionary treatments restore life to our patients.
RCLL is utilizing adult stem cells, those derived from the patient's
own blood, which eliminates the ethical and safety concerns associated
with embryonic and umbilical cord blood stem cells. Stem cells have the
ability to produce other cells identical to themselves or to
differentiate into specific cell lineages which can be used in the
regeneration and repair of damaged tissue.
|
